STAND. COM. REP. NO. 2131

Honolulu, Hawaii

RE: GOV. MSG. NO. 640

Honorable Ronald D. Kouchi

President of the Senate

Thirtieth State Legislature

Regular Session of 2019

State of Hawaii

Sir:

Your Committee on Commerce, Consumer Protection, and Health, to which was referred Governor's Message No. 640, submitting for study and consideration the nomination of:

Hawai'i Advisory Commission on Drug Abuse and Controlled Substances

G.M. No. 640

ANITA CIARLEGLIO, for a term to expire 06-30-2020,

begs leave to report as follows:

Your Committee reviewed the personal history, resume, and statement submitted by Anita Ciarleglio for service on the Hawaii Advisory Commission on Drug Abuse and Controlled Substances.

Your Committee received testimony in support of the nomination for the appointment of Anita Ciarleglio from the Department of Health and two individuals.

Upon review of the testimony, your Committee finds that Dr. Ciarleglio's background, knowledge, and commitment to public service qualify her to be nominated for appointment to the Hawaii Advisory Commission on Drug Abuse and Controlled Substances. Your Committee notes that Dr. Ciarleglio is a registered pharmacist and Assistant Professor at the Department of Pharmacy Practice of the University of Hawaii at Hilo, Daniel K. Inouye College of Pharmacy. Dr. Ciarleglio has spent almost twenty years in the pharmacy field and her numerous achievements include being instrumental in coordinating the University of Hawaii at Hilo Daniel K. Inouye College of Pharmacy curriculum, establishing a practice site at Maui Memorial Medical Center in Acute Medicine, developing the first Community Pharmacy Residency Program in Hawaii, and establishing a longitudinal rotation on medication safety in the elderly on Maui. Your Committee further finds that Dr. Ciarleglio's experience working on the neighbor islands, which are under-represented on the Hawaii Advisory Commission on Drug Abuse and Controlled Substances, and her extensive knowledge of pharmacological procedures, will be valuable assets to the Advisory Commission. Your Committee therefore recommends that Dr. Ciarleglio be appointed to the Hawaii Advisory Commission on Drug Abuse and Controlled Substances based on her knowledge, experience, and dedication to fostering her profession.

As affirmed by the record of votes of the members of your Committee on Commerce, Consumer Protection, and Health that is attached to this report, your Committee, after full consideration of the background, experience, and qualifications of the nominee, has found the nominee to be qualified for the position to which nominated and recommends that the Senate advise and consent to the nomination.

Respectfully submitted on behalf of the members of the Committee on Commerce, Consumer Protection, and Health,

____________________________

ROSALYN H. BAKER, Chair